Jeremy Reimann

Jeremy Reimann holds a bachelor’s degree in Neuroscience from Tulane University and a Master of Science in Public Health in Environmental Toxicology and Risk Assessment from Tulane University School of Public Health and Tropical Medicine. Mr. Reimann’s has over 10 years of experience progressing innovative pre-clinical, clinical, and translational research in diverse therapeutic areas across various sectors. Mr. Reimann’s current role is Clinical Project Manager at New World Medical, a small ophthalmology medical device company based in California, where he works cross functionally with KOLs, Medical Affairs, R&D and Regulatory Affairs stakeholders in the furtherance of clinical operational deliverables. Mr. Reimann is also Founder of Results In Site Clinical Research Consulting, an LLC offering consulting services to CROs and industry sponsors to support sound protocol design, data-driven study site selection, efficient study start-up activities and overall effective study recruitment and conduct. Mr. Reimann currently serves as an IRB member at Rutgers University, where he reviews diverse research protocols to ensure research is conducted in accordance with institutional policies, relevant standards and guidelines, and local and federal regulations.